MED MediClin AG

DGAP-News: MediClin AG: Group sales for the 1st quarter of 2022 significantly above the previous year's figure

DGAP-News: MediClin AG / Key word(s): Quarterly / Interim Statement
MediClin AG: Group sales for the 1st quarter of 2022 significantly above the previous year's figure

02.05.2022 / 12:40
The issuer is solely responsible for the content of this announcement.


Offenburg, 2 May 2022

Group sales for the 1st quarter of 2022 significantly above the previous year's figure

In the 1st quarter of 2022, the continuous improvement in occupancy rates in the rehabilitation clinics, which began in the second half of 2021, continued despite high incidences.

"Although the increase in Group sales over the first quarter of 2021 must be regarded in the context of the extremely weak prior-year quarter, the sales development in the first months of the year under review is nevertheless positive", commented Tino Fritz, CFO of MEDICLIN, on the current business development and added: "But we have also felt a significant increase in costs".

In the first quarter of 2022, Group sales of EUR 174.2 mill. were EUR 17.8 mill. or 11.4 % above the comparable prior-year quarter. On the costs side, the cost of raw materials and consumables used was EUR 5.3 mill. or 18.6 % above the prior-year value. At plus EUR 4.0 mill., energy costs and laboratory tests account for the major share in the increase in raw materials and consumables used. Staff costs rose only moderately by EUR 0.9 mill. or 0.8 %.

"At present, we assume that the pandemic will not have a significantly negative impact on the occupancy in the next two quarters, but we must assume that the much higher material expenses compared to the previous year will have a negative impact on earnings", said Dr. Joachim Ramming, CEO of MEDICLIN. However, he is confident that the development of sales and earnings on the back of rising demand for medical, therapeutic and nursing care services will lead to an increase in sales and earnings in the Group, provided that the consequences and effects of Russia's invasion of Ukraine will have no massive and lasting negative effect on the German economy.

The interim report as of 31 March 2022 is available from today under in German and English.

/

About MEDICLIN Aktiengesellschaft (Ticker: MED; WKN: 659 510)

MEDICLIN includes 35 clinics, seven care facilities and eleven medical care centers. The Group has around 8,350 beds/care places and employs around 10,200 people. In a strong network, MEDICLIN offers the pa-tient integrative care from the first visit to the doctor through the operation and subsequent rehabilitation to outpatient aftercare. Doctors, therapists and nurses work together in a carefully coordinated manner. MEDI-CLIN designs the care and support of people in need of care according to their individual needs and per-sonal needs.

MEDICLIN ─ a company of the Asklepios Group.



02.05.2022 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at


Language: English
Company: MediClin AG
Okenstraße 27
77652 Offenburg
Germany
Phone: +49 (0)781 488-326
Fax: +49 (0)781 488-184
E-mail:
Internet:
ISIN: DE0006595101
WKN: 659510
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1341131

 
End of News DGAP News Service

1341131  02.05.2022 

fncls.ssp?fn=show_t_gif&application_id=1341131&application_name=news&site_id=research_pool
EN
02/05/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on MediClin AG

 PRESS RELEASE

EQS-News: MEDICLIN ends successful 2024 financial year

EQS-News: MEDICLIN AG / Key word(s): Annual Report/Miscellaneous MEDICLIN ends successful 2024 financial year 28.03.2025 / 10:24 CET/CEST The issuer is solely responsible for the content of this announcement. Offenburg, March 28, 2025 MEDICLIN ends successful 2024 financial year   MEDICLIN Aktiengesellschaft (ticker: MED; WKN 659 510) today published its annual report for the year 2024. The group generated sales of EUR 748.8 mill., which corresponds to an increase of 2.6 % compared to the previous year (2023: EUR 730.1 mill.). MEDICLIN the highest sales in thus achieved...

 PRESS RELEASE

EQS-News: MEDICLIN beendet erfolgreiches Geschäftsjahr 2024

EQS-News: MEDICLIN AG / Schlagwort(e): Jahresbericht/Sonstiges MEDICLIN beendet erfolgreiches Geschäftsjahr 2024 28.03.2025 / 10:24 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Offenburg, 28. März 2025 MEDICLIN beendet erfolgreiches Geschäftsjahr 2024                                                                               Die MEDICLIN Aktiengesellschaft (Ticker: MED; WKN 659 510) hat heute ihren Geschäftsbericht für das Jahr 2024 veröffentlicht. Der Konzern erzielte einen Umsatz von 748,8 Mio. Euro, was einer Steigerung vo...

 PRESS RELEASE

EQS-News: MEDICLIN lädt zur virtuellen Bilanzpressekonferenz 2025 ein

EQS-News: MEDICLIN AG / Schlagwort(e): Konferenz/Sonstiges MEDICLIN lädt zur virtuellen Bilanzpressekonferenz 2025 ein 19.03.2025 / 15:18 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Offenburg, 19. März 2025 MEDICLIN lädt zur virtuellen Bilanzpressekonferenz 2025 ein Die MEDICLIN Aktiengesellschaft (Ticker: MED; WKN 659 510) lädt zur virtuellen Bilanzpressekonferenz 2025 ein. Diese wird am28. März 2025 um 11.00 Uhr (MEZ) stattfinden. Der Vorstand der MEDICLIN wird im Rahmen eines Webcasts über das Geschäftsjahr 2024, die aktuelle...

 PRESS RELEASE

EQS-News: MEDICLIN invites you to the 2025 virtual press conference o...

EQS-News: MEDICLIN AG / Key word(s): Conference/Miscellaneous MEDICLIN invites you to the 2025 virtual press conference on the financial statements for the year 2024 19.03.2025 / 15:18 CET/CEST The issuer is solely responsible for the content of this announcement. Offenburg, March 19, 2024 MEDICLIN invites you to the 2025 virtual press conference on the financial statements for the year 2024 MEDICLIN (Ticker: MED; WKN 659 510) invites you to the 2025 virtual press conference on the financial statements for the year 2024. The event will take place on March 28, 2025 at 1...

 PRESS RELEASE

EQS-News: MEDICLIN presents preliminary figures for the 2024 financial...

EQS-News: MEDICLIN AG / Key word(s): Preliminary Results MEDICLIN presents preliminary figures for the 2024 financial year 27.02.2025 / 13:03 CET/CEST The issuer is solely responsible for the content of this announcement. Offenburg, February 27, 2024 MEDICLIN presents preliminary figures for the 2024 financial year MEDICLIN increases its group sales in 2024 by 2.6% to EUR 748.8 mill. Group operating result reaches EUR 53.5 mill. (previous year: EUR 12.7 mill.) Capacity utilisation in the post-acute segment above 86% in every quarter MEDICLIN generated group sales of ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch